WELCOME TO PAWEL LISOWSKI RESEARCH WEBSITE
functionalgenomics.pl is a fearless research initiative advancing human genome engineering technology to drive the next generation gene therapyThe aim of functionalgenomics.pl is to deliver next-generation gene therapies for neurodevelopmental and neurodegenerative conditions throughout Somatic Cell Genome Editing program and Targeted Genome Editor Delivery Challenge including:
Gene repair technology development for somatic cell (post mitotic neurons, astrocytes and microglia).
Cell type specific delivery of therapeutic gene editing components using engineered next generation non viral particles.
Application of patient derived 3D human brain model systems driven by deep learning to support treament decisions in the context of personalized medicine by:
(1) high throughput phenotypic screening;
(2) drug screening and drug reporposing as suplementary strategies.
NOTE: Currently we’re prioritizing decoding and treatement of IRF2BPL-related disorders (NEDAMSS) through our latest research initiative. By supporting our mission, you help drive scientific progress and strengthen the IRF2BPL Support Group Europe. Your donation directly fuels research and innovation toward better treatments for those affected by IRF2BPL. This initiative helps to treat other neurodevelopmental and neurodegenerative diseases allowing for next generation technology development. You can also participate in the IRF2BPL study including gene therapy clinical trial. For inquiries please contact Dr. Pawel Lisowski directly.
NON PROFIT IRF2BPL Support Group Germany by Pawel Lisowski and Jens Kiefer IBAN: DE91 4306 0967 1280 088101
WE ARE SUPPORTED BY
tough genes
iDream
Eva
European Joint programme
IRF support europe
GetRadi
Alliance_logo_CMYK
